Organogenesis Holdings Inc (ORGO) stock news · rev $564.2M
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This ORGO news page leads with what Organogenesis Holdings Inc filed — not a scraped headline mill.
No cached 8-K sentence for ORGO yet. We will not pad this page with generic market recap.
Latest reported ORGO revenue for 2025-12-31 was $564.2M. Net income was $37.0M. Revenue was up 17.0% from 2024-12-31 to 2025-12-31. ORGO currently screens at market cap $301.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ORGO stock page; for the tape open the quote page.
ORGO stock news FAQ
What are ORGO's latest revenue and net income?
Latest cached Organogenesis Holdings Inc (ORGO) revenue for Dec 31, 2025 was $564.2M. Net income was $37.0M. Statements: https://lician.com/financials/orgo
How did ORGO revenue change from the prior cached period?
Cached Organogenesis Holdings Inc (ORGO) revenue was up 17.0% from $482.0M (Dec 31, 2024) to $564.2M (Dec 31, 2025). Statements: https://lician.com/financials/orgo
What is ORGO's market cap?
Organogenesis Holdings Inc (ORGO) market cap is $301.1M on the latest cached fundamentals snapshot.
What kind of company is ORGO?
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is ORGO stock news listed?
Cached stock news for Organogenesis Holdings Inc (ORGO) is listed at https://lician.com/news/orgo. Filings: https://lician.com/sec/orgo
Not investment advice.